[1]
“Post-Approval Change Management for Modified Release Solid Oral Dosage Forms: A Comparative Regulatory Review of the United States, the Republic of Korea and the GCC Variation Guidelines”, Int. J. Pharm. Sci. Drug Res., vol. 18, no. 5, Sep. 2026, doi: 10.25004/.